Aromatization of androgens by human breast cancer
- PMID: 156971
- DOI: 10.1016/0039-128x(79)90027-8
Aromatization of androgens by human breast cancer
Abstract
The metabolism of dehydroepiandrosterone and testosterone by human mammary tumor was investigated. Estrogen synthesis from dehydroepiandrosterone was observed in 9 of 10 estrogen-receptor-negative tumors and only in 2 of 8 receptor-positive tumors (p less than 0.025). Conversion of testosterone to estrogens was observed in 7 of 8 receptor-negative and 2 of 7 receptor-positive tumors. Tumors which are capable of transforming dehydroepiandrosterone to estrogens were also able to aromatize testosterone suggesting that the presence of the aromatase enzyme is inherent to certain tumor cells. No estrogen formation was detected by the mitochondrial-microsomal fraction of normal breast cells while fractions from both fat cell and tumor cell showed estrogen synthesis. Estrogen formation by tumor cell fraction ranged from 5 to 190 times that observed for fat cells. The physiological significance of these results in the neoplastic tissue and its relationship to hormone dependence are discussed.
Similar articles
-
Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.J Steroid Biochem Mol Biol. 2005 Jan;93(1):25-34. doi: 10.1016/j.jsbmb.2004.11.005. Epub 2005 Jan 27. J Steroid Biochem Mol Biol. 2005. PMID: 15748829
-
Steroid metabolism by human mammary carcinoma.Steroids. 1976 Oct;28(4):561-74. doi: 10.1016/0039-128x(76)90024-6. Steroids. 1976. PMID: 137557
-
Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.Cancer Res. 1982 Aug;42(8 Suppl):3373s-3377s. Cancer Res. 1982. PMID: 6211227
-
Aromatase in the context of breast and endometrial cancer. A review.Minerva Endocrinol. 2006 Mar;31(1):47-60. Minerva Endocrinol. 2006. PMID: 16498363 Review.
-
Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.Oncotarget. 2017 May 2;8(18):30552-30562. doi: 10.18632/oncotarget.15547. Oncotarget. 2017. PMID: 28430630 Free PMC article. Review.
Cited by
-
Conversion to estriol in "normal", benign and malignant human breast tissues.J Cancer Res Clin Oncol. 1990;116(3):271-4. doi: 10.1007/BF01612902. J Cancer Res Clin Oncol. 1990. PMID: 2370253 Free PMC article.
-
Aminoglutethimide. Penetration of the blood brain barrier.Invest New Drugs. 1986;4(3):237-40. doi: 10.1007/BF00179589. Invest New Drugs. 1986. PMID: 3818227
-
Recent advances in studies on estrogen biosynthesis.J Endocrinol Invest. 1979 Oct-Dec;2(4):445-60. doi: 10.1007/BF03349349. J Endocrinol Invest. 1979. PMID: 395188 Review.
-
Anti-Angiogenic Treatments Interact with Steroid Secretion in Inflammatory Breast Cancer Triple Negative Cell Lines.Cancers (Basel). 2021 Jul 21;13(15):3668. doi: 10.3390/cancers13153668. Cancers (Basel). 2021. PMID: 34359570 Free PMC article.
-
Correlation of aromatase activity with histological differentiation of breast cancer--a morphometric analysis.Breast Cancer Res Treat. 1988 Sep;12(1):31-5. doi: 10.1007/BF01805737. Breast Cancer Res Treat. 1988. PMID: 3196885
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources